171 related articles for article (PubMed ID: 11280553)
1. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
Kono T; Nomura M; Kasai S; Kohgo Y
Am J Gastroenterol; 2001 Mar; 96(3):793-7. PubMed ID: 11280553
[TBL] [Abstract][Full Text] [Related]
2. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
3. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
Takagi T; Naito Y; Okuda T; Uchiyama K; Adachi S; Mizushima K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis.
Sandborn WJ; Tremaine WJ; Schroeder KW; Steiner BL; Batts KP; Lawson GM
Am J Gastroenterol; 1993 May; 88(5):640-5. PubMed ID: 8480724
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
Steinhart AH; Brzezinski A; Baker JP
Am J Gastroenterol; 1994 Feb; 89(2):179-83. PubMed ID: 8304299
[TBL] [Abstract][Full Text] [Related]
6. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
[TBL] [Abstract][Full Text] [Related]
7. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
Iizuka M; Itou H; Konno S; Shirasaka T; Horie Y; Shindo K; Watanabe S
Gut; 2006 Oct; 55(10):1523. PubMed ID: 16966708
[No Abstract] [Full Text] [Related]
9. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
Lewis JD; Lichtenstein GR; Stein RB; Deren JJ; Judge TA; Fogt F; Furth EE; Demissie EJ; Hurd LB; Su CG; Keilbaugh SA; Lazar MA; Wu GD
Am J Gastroenterol; 2001 Dec; 96(12):3323-8. PubMed ID: 11774944
[TBL] [Abstract][Full Text] [Related]
10. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
Frühmorgen P; Demling L
Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
[TBL] [Abstract][Full Text] [Related]
11. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
12. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
[TBL] [Abstract][Full Text] [Related]
13. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
Uehara T; Kato K; Ohkusa T; Sugitani M; Ishii Y; Nemoto N; Moriyama M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S62-6. PubMed ID: 20586868
[TBL] [Abstract][Full Text] [Related]
15. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
Monteleone G; Caprioli F
Curr Opin Investig Drugs; 2007 May; 8(5):423-8. PubMed ID: 17520872
[TBL] [Abstract][Full Text] [Related]
16. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
[TBL] [Abstract][Full Text] [Related]
17. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the mucosa with local anaesthetics in ulcerative colitis.
Björck S; Dahlström A; Johansson L; Ahlman H
Agents Actions; 1992; Spec No():C60-72. PubMed ID: 1442337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
